BVMed sets up active implantables group:
This article was originally published in Clinica
BVMed, the German medical device industry association, has established a new interest group covering active implantables. The move is necessary, says BVMed, following the merger of the International Association of Medical Prosthesis Manufacturers (IAPM) and EUCOMED, the European medical device industry association. Until the merger, pacemaker and implantable defibrillator manufacturers were represented by IAPM Germany, whose offices have now closed. As part of an effort to demonstrate the merits and advantages of active implantables to the public, the new group is organising an innovation congress entitled "Effects of the Health Care Reform on Medical Innovations in Cardiology" to be held on February 17 2000 in Berlin.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.